| 名稱 | EML4(E13)-ALK(E20) Translocation |
| 型號 | CBP20209D |
| 報價 |  |
| 特點 | EML4(E13)-ALK(E20) Translocation |
產品搜索
相關文章
聯系我們
產品展示 / PRODUCTS
基因檢測標準品 > Translocation > CBP20209DEML4(E13)-ALK(E20) Translocation
- 詳細內容
EML4(E13)-ALK(E20) Translocation EML4(E13)-ALK(E20) Translocation
| Introduction | |
| Format | DNA |
| Description | EML4-ALK results from the fusion of EML4 and ALK, resulting in constitutive kinase activity, transformation in cultured cells, and tumor formation in mouse models . EML4-ALK fusions have been associated with non-small cell lung cancer . |
| Technical Data | |
| Left Gene | EML4（E13） |
| Left Breakpoint | chr2:425****6:+ |
| Right Gene | ALK（E20） |
| Right Breakpoint | chr2:294****4:- |
| %AF | 50% |
| Buffer | Tris-EDTA |
Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| RNA electrophoresis | Download for COA |
| Sanger sequencing | Download for COA |
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">
